Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 14, 2014; 20(34): 12226-12232
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12226
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12226
Variable | Median, (range) (n = 83) |
Age, yr | 65 (23– 88) |
Gender | |
Men | 39 (53) |
Women | 44 (47) |
Tumor size, cm | 3.1 (0.5-10.8) |
Missing | n = 4 |
Presenting symptoms | |
Weight loss > 10% | 40 (48) |
Smoking | 21 (25) |
Pain | 47 (57) |
Jaundice | 65 (78) |
Margin status | |
R0 | 56 (67) |
R1 | 22 (27) |
R2 | 5 (6) |
1 yr overall survival | |
R0 | 72.2% |
R1/2 | 64.0% |
Lymph Node Status | |
Positive | 30 (36) |
Negative | 23 (29) |
Missing | 30 (35) |
Average lymph node ratio | 16.0% |
Portal vein resection | 13 (15) |
Median follow-up in months (IQR) | 18.5 (11-48.5) |
Median survival | 23 mo |
5 yr survival | 29.4% |
- Citation: Jamal MH, Doi SAR, Moser AJ, Dumitra S, Khalil JA, Simoneau E, Chaudhury P, Onitilo AA, Metrakos P, Barkun JS. McGill Brisbane Symptom Score for patients with resectable pancreatic head adenocarcinoma. World J Gastroenterol 2014; 20(34): 12226-12232
- URL: https://www.wjgnet.com/1007-9327/full/v20/i34/12226.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i34.12226